Результаты поиска

Акушерская анестезия/анагезия не влияет на курс болезни при множественном склерозе: 10- Ретроспективное когортное исследование.

ЦЕЛИ: Множественный склероз (МС) часто встречается у молодых женщин, а воздействие акушерской анестезии/анагезии на болезнь плохо изучено. Ни одно из предыдущих исследований не было посвящено изучению состояния заболевания женщин, работающих в Чешской Республике. Цель этого исследования заключалась в оценке случаев или отсутствия рецидивов 6-month Послеродовый период в MS parturients с акушерской анестезией и без нее. МАТЕРИАЛЫ И МЕТОДЫ: Мы ретроспективно изучили все поставки (n = 58,455) в университетской больнице Брно 2004 в адрес 2013 и выявила женщин, имеющих ICD-10 код G35 (MS), зарегистр

Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care.

IntroductionInfection is an important complication in cancer patients, which frequently leads to or prolongs hospitalization, and can also lead to acute organ dysfunction (severe sepsis) and eventually death. While cancer patients are known to be at higher risk for infection and subsequent complications, there is no national estimate of the magnitude of this problem. Our objective was to identify cancer patients with severe sepsis and to project these numbers to national levels.MethodsData for all 1999 hospitalizations from six states (Florida, Massachusetts, New Jersey, New York, Virginia, an

Воздействие факторов образа жизни после инфекционного мононуклеоза на риск множественных склерозов.

ОКРУЖАЮЩАЯ СРЕДА: Накопленные данные свидетельствуют о том, что вирус Эпштейн-Барр (ЭБВ) имеет решающее значение для развития множественного склероза (МС), а неадекватная борьба с инфекциями, возможно, способствует возникновению заболеваний. Было установлено, что в прошлом инфекционный мононуклеоз (IM) взаимодействовал с курением, ожирением и воздействием солнца. Мы стремились изучить потенциальные взаимосвязи между историей КМ и следующими факторами риска для КМ: пассивное курение, потребление алкоголя, потребление рыбы, состояние витамина D, продолжительность сна среди подростков и качество

Comprehensive Study of the Risk Factors for Medication-Related Osteonecrosis of the Jaw Based on the Japanese Adverse Drug Event Report Database.

Medication-related osteonecrosis of the jaw (MRONJ) is associated with many drugs, including bisphosphonates (BPs). BPs are associated with atypical femoral fractures and osteonecrosis of the external auditory canal. Thus, many drugs are reported to cause adverse effects on bone. This study aimed to investigate the effects of drugs and patient backgrounds regarding osteonecrosis-related side effects, including MRONJ. This study used a large voluntary reporting database, namely, the Japanese Adverse Drug Event Report database. First, we searched for risk factors related to MRONJ using volcano p

The issue with incidence: a scoping review of reported medication-related osteonecrosis of the jaws (MRONJ) incidence around the globe.

BACKGROUND: Medication-related osteonecrosis of the jaws (MRONJ) can be a debilitating condition which is challenging to manage. While vast literature exists surrounding MRONJ, many studies have small participant numbers and are heterogeneous in design, leaving unanswered questions and making evidence-based practice challenging. OBJECTIVE: Provide an overview of recent MRONJ incidence data, over a 5-year period, identify potential issues in reporting MRONJ cases and propose changes for future reporting. ELIGIBILITY CRITERIA: Studies with original data regarding MRONJ incidence published from

Immunoglobulin replacement therapy in secondary hypogammaglobulinemia.

Immunoglobulin (Ig) replacement therapy dramatically changed the clinical course of primary hypogammaglobulinemias, significantly reducing the incidence of infectious events. Over the last two decades its use has been extended to secondary antibody deficiencies, particularly those related to hematological disorders as lymphoproliferative diseases (LPDs) and multiple myeloma. In these malignancies, hypogammaglobulinemia can be an intrinsic aspect of the disease or follow chemo-immunotherapy regimens, including anti-CD20 treatment. Other than in LPDs the broadening use of immunotherapy (e.g., ri

Т-клеточное истощение, вызванное терапией БиТЕ в множестве миэломы: снижение инфекционного риска с помощью свободных от лечения интервалов.

Множественная миелома (ММ), которая является высокоизлечимой, но до сих пор неизлечимой гематологической халатностью, потребовала постоянного наблюдения и лечения на протяжении всей жизни пациента. Новые классы терапии, такие, как химерик антиген-рецептор (CAR) T-клеток, которые представляют собой one- вливание времени, бросило вызов постоянной системе лечения. По сравнению с ранее известной стандартной терапией T-клеточная терапия CAR, а также биконкретная терапия T-клеточной терапии (BitE) были отмечены для того, чтобы вызвать более глубокие реакции, которые, как правило, являются устойчивым

The Protective Effects of Sesamin against Cyclophosphamide-Induced Nephrotoxicity through Modulation of Oxidative Stress, Inflammatory-Cytokines and Apoptosis in Rats.

Cyclophosphamide is an anticancer drug with a wide spectrum of clinical uses, but its typical side effects are multiple complications, including nephron toxicity. The possible molecular mechanism of the nephroprotective action of sesamin (SM) against cyclophosphamide (CP) induced renal toxicity was investigated in rats by understanding oxidative stress and inflammatory cytokines. In this study, rats were arbitrarily grouped into the following four groups: a normal control group (CNT); a CP-induced toxicity group; a treatment group with two doses of sesamin SM10 and SM20; a group with sesamin (

< < Эльранатамб > > , < < Множественная миелома > > и < < Гемодиализ > > .

Пациенты, страдающие повторной или повторной болезнью миэломы (RRMM), страдающие почечным расстройством, зависящим от диализа, сталкиваются с ограниченными терапевтическими возможностями из-за исключения из клинических испытаний, отсутствия руководящих принципов, основанных на фактических данных, и более низких результатов. Биотечные антитела, направленные против антигена B-клеток (BCMA), продемонстрировали свои способности к лечению RRMM, но остаются недостаточно изученными в этой уязвимой группе населения. Чтобы проиллюстрировать этот вопрос, мы вносим пример: 68-year-old Самка с тройным кла

Promising Experimental Treatments for Lupus Nephritis: Key Talking Points and Potential Opportunities.

Lupus nephritis (LN) is a frequent and serious complication of systemic lupus erythematosus (SLE), impairing patients' quality of life and significantly increasing mortality. Despite optimizing the use of conventional immunosuppressants and other biological drugs, its management remains unsatisfactory. This is mainly due to the heterogeneity of SLE, but also to insufficiently effective treatment regimens and clinical trial limitations (strict criteria, low number of patients included, and side effects). Most clinical trials of new biological therapies have failed to meet their primary endpoint

The potential of oral healthcare providers to recognise early systemic disease.

Like many other body structures, the mouth is often affected by disease that principally arises from, or targets, several tissue sites. Indeed, systemic disorders can manifest on the oral mucosa as the first, only, or become the most severe manifestation of a systemic disease and/or become the most significant factor to adversely affect an individual's quality of life. Oral healthcare providers (dentists, therapists and hygienists) may be the first to observe an abnormality in the mouth which sometimes indicates a significant systemic disease unknown to the patient or their general medical pra

Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology.

Heart failure with preserved ejection fraction (HFpEF) is increasingly recognized in cancer patients and survivors, yet it remains underdiagnosed and its epidemiology largely unknown. This statement underscores the imperative need to include HFpEF in the cardiotoxicities identified during or after anticancer treatments. It also highlights the prognostic value of pre-existing HFpEF for periprocedural and cardiotoxicity risk and it discusses the challenges in the diagnosis and treatment of HFpEF in cancer patients. It also explores the aetiologic role of anticancer therapies (chemotherapy, targe

Регулирование IFNG-AS1 и UCHL1-AS1 в периферальных кровяных клетках пациентов с множественным склерозом: IFNG-AS1 как потенциальный диагностический биомаркер.

Множественный склероз (MS) — нейродегенеративное и воспалительное заболевание, затрагивающее серую и белую материю в мозгу. Из-за весьма изменчивого представления MS чрезвычайно трудно сделать надежную долгосрочную диагностику, основанную исключительно на первоначальных клинических выводах. В ходе недавних исследований было продемонстрировано, что некодирующие РНК (lncRNA) в течение длительного времени играют определенную роль в качестве перспективных биомаркеров, которые могут предложить данные для прогнозирования возникновения и развития болезни. МЕТОДЫ: В состав группы по сбору проб крови б

Burnout and job satisfaction among hematologists: A cross-sectional study.

Burnout and job satisfaction represent significant challenges among healthcare professionals, especially within high-stress specialties such as hematology. Despite the demanding nature of the field, burnout and job satisfaction among hematologists remain underexplored. This study aimed to evaluate the levels of burnout and job satisfaction in this population and to investigate their associations with sociodemographic variables. This cross-sectional study included 139 hematologists practicing in Turkey. Participants completed a sociodemographic questionnaire, Maslach Burnout Inventory and Job S

Waldenström macroglobulinemia treatment algorithm 2018.

Waldenström macroglobulinemia is often an indolent disorder, and many patients are candidates for observation with careful monitoring. For symptomatic patients, one must distinguish between those patients whose symptoms are related to immunologic manifestations associated with the IgM monoclonal protein and those that have symptoms related to progressive marrow and nodal infiltration with lymphoplasmacytic lymphoma. In Waldenström macroglobulinemia, the driver for therapy in the majority of patients is progressive anemia, secondary to bone marrow replacement by lymphoplasmacytic lymphoma. Rece

Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma.

Multiple myeloma (MM) is a very heterogeneous disease with multiple symptoms and clinical manifestations. MM affects mainly elderly patients and is difficult to manage in the presence of comorbidities, polypharmacy, frailty and adverse events of disease-targeted drugs. The rapid changes in MM treatment resulting from constant innovations in this area, together with the introduction of numerous new drugs with distinct mechanisms of action and toxicity profiles, have led to an increased complexity in the therapeutic decision-making and patient management processes. The prolonged exposure to nove

Совпадение в полном тексте источника
… Supportive measures encompass the removal of the precipitating factors of nephropathy, with vigorous hydration (2 L/m 2 /day) with particular attention to the fluid balance, especially in patients with reduced urine output and cardiac disease. …

Potential of histone deacetylase 6 inhibitors in alleviating chemotherapy-induced peripheral neuropathy.

BackgroundHistone deacetylase 6 (HDAC6), belonging to class IIb of histone deacetylases, regulates the acetylation of the cytoplasmic protein α-tubulin. The overexpression of HDAC6 is linked to the development of tumors, and inhibiting HDAC6 is known to trigger apoptosis in multiple myeloma cells. In addition to its application in cancer treatment, bortezomib, a proteasome inhibitor, is widely used in managing multiple myeloma and has shown effectiveness in patients with both newly diagnosed and relapsed disease. However, the treatment regimen may be delayed or discontinued due to the risk of

Изучение сегментации мозга с участием многих папологов: от глубокого анализа знаний на основе физического объема до компонентов.

Обнаружение и сегментация аномалий мозга с использованием магнитного резонансного воображения (MRI) является важной задачей, которая в настоящее время четко закрепляется как на уровне исследований, так и на уровне клинического производства роль алгоритмов АИ как вспомогательных инструментов. Хотя эффективность современных моделей возрастает и во многих случаях достигает уровней точности радиологов и других экспертов, все еще необходимо провести много исследований по вопросу о направлении углубленной и транспарентной оценки правильных результатов и неудач, особенно в том, что касается важных ас

Sepsis in multimorbidity: a domain-based framework for systemic vulnerability and precision care.

Sepsis is a leading cause of morbidity and mortality, amplified by multimorbidity. This narrative review synthesizes epidemiological, pathophysiological, and immunological evidence to show how prevalent conditions-type 2 diabetes and obesity, heart failure and cerebrovascular disease, COPD, chronic kidney disease, cancer/HIV, and severe mental illness-reshape sepsis biology and outcomes. Convergent mechanisms include low-grade inflammation, impaired innate and adaptive immunity, endothelial injury with immunothrombosis/NETosis, barrier disruption with dysbiosis, and neuroendocrine maladaptatio

Beyond Formulation: Contributions of Nanotechnology for Translation of Anticancer Natural Products into New Drugs.

Nature is the largest pharmacy in the world. Doxorubicin (DOX) and paclitaxel (PTX) are two examples of natural-product-derived drugs employed as first-line treatment of various cancer types due to their broad mechanisms of action. These drugs are marketed as conventional and nanotechnology-based formulations, which is quite curious since the research and development (R&D) course of nanoformulations are even more expensive and prone to failure than the conventional ones. Nonetheless, nanosystems are cost-effective and represent both novel and safer dosage forms with fewer side effects due to m